Liu Henry, Fox Charles J, Zhang Shihai, Kaye Alan D
Tulane University Medical Center, 1430 Tulane Avenue, SL-4, New Orleans, LA 70112, USA.
Anesthesiol Clin. 2010 Dec;28(4):723-38. doi: 10.1016/j.anclin.2010.09.001.
Cardiovascular diseases are a leading cause of hospitalizations and death in the United States and elsewhere in the world. Developing new therapeutic agents for cardiovascular diseases has always been the priority for the pharmaceutical industry because of the huge potential market for these drugs. Some of these newer drugs are frequently used in the practice of cardiovascular anesthesiology. This article reviews the recent advances in cardiovascular medications related to the practice of cardiac anesthesia.
心血管疾病是美国以及世界其他地区住院和死亡的主要原因。由于这些药物具有巨大的潜在市场,开发用于治疗心血管疾病的新型治疗药物一直是制药行业的首要任务。其中一些新药经常用于心血管麻醉实践中。本文综述了与心脏麻醉实践相关的心血管药物的最新进展。